1 Industry Report(제약산업), "한국신용평가정보"
2 Korea Food & Drug Administration, "제네릭의약품 정보방. Copyrightⓒ"
3 Meyer, M. C, "United States Food and Drug Administration requirements for approval of generic drug products" 62 : 4-, 2001
4 Perry, G, "The European pharmaceutical market in review: 2006 and beyond" 4 : 4-, 2006
5 Hellstrom, J, "Side effects of generic competition" 5 : 203-, 2004
6 Kanavos, P, "Pharmacy discounts on generic medicines in France: is there room for further efficiency savings" 23 : 2467-, 2007
7 Meredith, P. A, "Generic drugs. Therapeutic equivalence" 15 : 233-, 1996
8 Mott, D. A, "Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution" 40 : 662-, 2002
9 Johnston, A, "Challenges of therapeutic substitution of drugs for economic reasons: focus on CVD prevention" 26 : 871-, 2010
10 Meredith, P, "Bioequivalence and other unresolved issues in generic drug substitution" 25 : 2875-, 2003
1 Industry Report(제약산업), "한국신용평가정보"
2 Korea Food & Drug Administration, "제네릭의약품 정보방. Copyrightⓒ"
3 Meyer, M. C, "United States Food and Drug Administration requirements for approval of generic drug products" 62 : 4-, 2001
4 Perry, G, "The European pharmaceutical market in review: 2006 and beyond" 4 : 4-, 2006
5 Hellstrom, J, "Side effects of generic competition" 5 : 203-, 2004
6 Kanavos, P, "Pharmacy discounts on generic medicines in France: is there room for further efficiency savings" 23 : 2467-, 2007
7 Meredith, P. A, "Generic drugs. Therapeutic equivalence" 15 : 233-, 1996
8 Mott, D. A, "Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution" 40 : 662-, 2002
9 Johnston, A, "Challenges of therapeutic substitution of drugs for economic reasons: focus on CVD prevention" 26 : 871-, 2010
10 Meredith, P, "Bioequivalence and other unresolved issues in generic drug substitution" 25 : 2875-, 2003